Cargando...

Crystal structure of dihydropyrimidine dehydrogenase, a major determinant of the pharmacokinetics of the anti-cancer drug 5-fluorouracil

Dihydropyrimidine dehydrogenase catalyzes the first step in pyrimidine degradation: the NADPH-dependent reduction of uracil and thymine to the corresponding 5,6-dihydropyrimidines. Its controlled inhibition has become an adjunct target for cancer therapy, since the enzyme is also responsible for the...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Dobritzsch, Doreen, Schneider, Gunter, Schnackerz, Klaus D., Lindqvist, Ylva
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2001
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC145429/
https://ncbi.nlm.nih.gov/pubmed/11179210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/emboj/20.4.650
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!